Amoils Misha, Crisham Janik Mary, Lustig Lawrence R
Department of Otolaryngology, Stanford University, Stanford, California.
Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
JAMA Otolaryngol Head Neck Surg. 2015 Oct;141(10):923-926. doi: 10.1001/jamaoto.2015.1670. Epub 2015 Sep 10.
Although congenital diaphragmatic hernia (CDH) may be associated with sensorineural hearing loss (SNHL), to our knowledge, no studies have yet identified the pattern of this hearing loss or definitive independent risk factors that may place this population at higher risk.
To characterize the type and degree or SNHL in CDH survivors and better characterize perinatal risk factors.
DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study of CDH survivors who had a pure-tone audiogram available for review followed at a multidisciplinary clinic.
Treatment for CDH at birth.
Audiograms were used to calculate pure-tone average (PTA) for the most severely affected side and classify SNHL as normal (<20 dB), mild (20-39 dB), moderate (>40-59 dB), severe (≥60 dB), or profound (≥80 dB). Clinically significant SNHL was defined as a PTA of at least 40 dB. Perinatal data evaluated included demographics, characteristics of CDH and neonatal respiratory course, peak total and direct bilirubin levels, exposure to ototoxic drugs, need for supplemental oxygen at discharge, and results of newborn hearing screen. Univariate analysis was conducted to examine the relationship between these variables and (1) any SNHL or (2) significant SNHL.
Fifty patients were included. Audiograms were performed at age 2.7 ± 2.3 years (range, 0.5-10.7 years). Of the 50 patients, 28 (56%) had any SNHL and 9 of the 28 (32%) had significant SNHL (PTA ≥ 40 dB). Any SNHL was not significantly different (P = .42) by newborn hearing screen results: 5 of 7 children (71%) who failed the screening were classified as having any SNHL, and 20 of 40 children (50%) who passed were classified as having any SNHL. While no variables were significantly associated with any SNHL, multiple significant associations were found with significant SNHL: extracorporeal membrane oxygenation support (P = .02), nonprimary CDH repair (P = .01), prolonged ventilation (≥14 days) (P = .001), and high neonatal furosemide exposure (P = .03).
Sensorineural hearing loss is prevalent among children with CDH. As would be expected, significant SNHL (PTA ≥ 40 dB) in this cohort was associated with markers of more severe CDH with a more complicated neonatal hospital course. Overall close follow-up for hearing and speech development, including routine audiology testing, is indicated in children with CDH.
虽然先天性膈疝(CDH)可能与感音神经性听力损失(SNHL)相关,但据我们所知,尚无研究确定这种听力损失的模式或明确的独立危险因素,这些因素可能使该人群面临更高风险。
描述CDH幸存者中SNHL的类型和程度,并更好地描述围产期危险因素。
设计、设置和参与者:这是一项对CDH幸存者的回顾性队列研究,这些幸存者有多学科诊所可查的纯音听力图。
出生时对CDH进行治疗。
使用听力图计算受影响最严重一侧的纯音平均听阈(PTA),并将SNHL分类为正常(<20 dB)、轻度(20 - 39 dB)、中度(>40 - 59 dB)、重度(≥60 dB)或极重度(≥80 dB)。具有临床意义的SNHL定义为PTA至少为40 dB。评估的围产期数据包括人口统计学、CDH和新生儿呼吸过程的特征、总胆红素和直接胆红素峰值水平、耳毒性药物暴露、出院时补充氧气的需求以及新生儿听力筛查结果。进行单因素分析以检查这些变量与(1)任何SNHL或(2)显著SNHL之间的关系。
纳入了50名患者。在2.7±2.3岁(范围0.5 - 10.7岁)时进行了听力图检查。在这50名患者中,28名(56%)有任何SNHL,28名中的9名(32%)有显著SNHL(PTA≥40 dB)。新生儿听力筛查结果显示,任何SNHL无显著差异(P = 0.42):7名筛查未通过的儿童中有5名(71%)被分类为有任何SNHL,40名通过筛查的儿童中有20名(50%)被分类为有任何SNHL。虽然没有变量与任何SNHL显著相关,但发现多个变量与显著SNHL有显著关联:体外膜肺氧合支持(P = 0.02)、非初次CDH修复(P = 0.01)、长时间通气(≥14天)(P = 0.001)和高剂量新生儿速尿暴露(P = 0.03)。
感音神经性听力损失在CDH儿童中很常见。正如预期的那样,该队列中具有临床意义的SNHL(PTA≥40 dB)与更严重的CDH及更复杂的新生儿住院病程相关。建议对CDH儿童进行全面的听力和言语发育密切随访,包括常规听力测试。